Scott Dreyer
Corporate Officer/Principal bij COLLEGIUM PHARMACEUTICAL, INC.
Vermogen: 5 M $ op 29-02-2024
Profiel
Scott Dreyer occupies the position of Chief Commercial Officer & Executive VP of Collegium Pharmaceutical, Inc.
In the past Mr. Dreyer occupied the position of Vice President-US Hospital & Oncology Sales at Merck & Co., Inc., Chief Marketing Officer for Biogen, Inc. and Senior VP-Marketing & Commercial Operations at The Medicines Co.
Mr. Dreyer received an undergraduate degree from the University of Messiah.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
26-02-2024 | 138 918 ( 0.43% ) | 5 M $ | 29-02-2024 |
Actieve functies van Scott Dreyer
Bedrijven | Functie | Begin |
---|---|---|
COLLEGIUM PHARMACEUTICAL, INC. | Corporate Officer/Principal | 10-07-2018 |
Eerdere bekende functies van Scott Dreyer
Bedrijven | Functie | Einde |
---|---|---|
THE MEDICINES COMPANY | Sales & Marketing | 01-12-2017 |
BIOGEN INC. | Sales & Marketing | 01-09-2016 |
MERCK & CO., INC. | Corporate Officer/Principal | 01-01-2013 |
Opleiding van Scott Dreyer
University of Messiah | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 3 |
---|---|
MERCK & CO., INC. | Health Technology |
BIOGEN INC. | Health Technology |
COLLEGIUM PHARMACEUTICAL, INC. | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
The Medicines Co.
The Medicines Co. Pharmaceuticals: MajorHealth Technology The Medicines Co. is a biopharmaceutical company, which focuses on saving lives, alleviating suffering and contributing to the economics of healthcare by focusing on acute and intensive care hospitals worldwide. The firm markets its brands Angiomax, Cleviprex, injectable emulsion, Ionsys, Kengreal, Minocin for injection, and Orbactiv. The company was founded by Clive A. Meanwell, Helmut Giersiefen, John W. Villiger and T. Scott Johnson on July 31, 1996 and is headquartered in Parsippany, NJ. | Health Technology |